Skip to main content
. 2021 Mar 6;60(6):685–710. doi: 10.1007/s40262-021-00997-0
Information on pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs can help to optimize treatment.
Population pharmacokinetics and Bayesian dose adjustment can help to optimize dose adjustment.
There is still a significant knowledge gap for many of the tuberculosis drugs.